NC State opens Sheltie genetics study on gallbladder mucocele: full analysis

North Carolina State University is recruiting Shetland Sheepdogs for a new genetics study focused on the underlying cause of gallbladder mucocele formation, a potentially life-threatening biliary disorder seen disproportionately in Shelties and several other small-breed dogs. The study, led by Jody Gookin at NC State’s College of Veterinary Medicine, opened April 22, 2026, and is slated to continue through March 1, 2027. Participation involves a one-time DNA sample, collected by blood when possible or by cheek swab, along with basic information about the dog. (cvm.ncsu.edu)

The recruitment criteria are notable because they include both Shetland Sheepdogs already diagnosed with a gallbladder mucocele, or that have had surgery for one, and Shelties at least 10 years old that can undergo free ultrasound screening at NC State. That design points to a case-control approach, comparing affected dogs with older dogs that appear unaffected, which could help researchers sort true disease-associated variants from incidental breed background. That matters in a condition where diagnosis, especially early disease, has historically been complicated by variability in ultrasound interpretation and disease staging. (cvm.ncsu.edu)

This isn’t NC State’s first pass at the question. A 2010 paper reported a strong association between gallbladder mucocele formation and an insertion mutation in ABCB4, particularly in Shetland Sheepdogs, with affected dogs in that study typically carrying the mutation in heterozygous form. But that association did not fully explain the disease, and later work in the field raised questions about whether ABCB4 alone accounts for risk across populations. More recently, Gookin and colleagues reported that dogs with gallbladder mucocele formation show marked loss of CFTR-dependent anion secretion and reduced CFTR protein in gallbladder tissue, even though whole-genome sequence comparisons did not find meaningful differences in CFTR coding variants between low-risk, high-risk, and affected dogs. (comparative-hepatology.biomedcentral.com)

That 2024 CFTR work reframed the disease as a cystic fibrosis-like disorder of the canine gallbladder driven by acquired CFTR dysfunction rather than a straightforward inherited CFTR mutation. In NC State’s own description of the findings, Gookin said the next step would be to examine the entire genome for other mutations that could make dogs susceptible to developing the disease. The newly posted 2026 enrollment notice looks like a direct continuation of that strategy, now focused on building the sample set needed to identify those susceptibility factors in a breed known to be at elevated risk. (news.ncsu.edu)

Broader clinical context also supports a multifactorial model. Merck Veterinary Manual notes that gallbladder mucocele formation is associated with middle to older age, breed predisposition, endocrinopathies such as hyperadrenocorticism and hypothyroidism, hyperlipidemia, and gallbladder dysmotility. AKC Canine Health Foundation materials describing related NC State work say affected dogs often have concurrent hypothyroidism, Cushing’s disease, and/or hyperlipidemia, and that metabolomic studies have identified abnormalities in lipid, bile acid, amino acid, and energy pathways. Taken together, the literature suggests the current study is less about finding a single silver-bullet mutation and more about clarifying genetic susceptibility within a broader metabolic and physiologic syndrome. (merckvetmanual.com)

Why it matters: For veterinarians, this study is a reminder that gallbladder mucocele remains an active area of translational research, not a solved disease. In practice, clinicians are still managing a condition that can move from incidental ultrasound finding to obstruction, rupture, or bile peritonitis, and where breed, lipid status, endocrine disease, and motility may all shape risk and outcomes. If this recruitment effort identifies stronger genetic markers in Shetland Sheepdogs, it could eventually sharpen screening, counseling, breeding discussions, and perhaps earlier intervention strategies for at-risk patients. It may also help explain why some older Shelties remain unaffected while others progress to clinically significant disease. (merckvetmanual.com)

There doesn’t appear to be outside expert commentary yet specifically on this 2026 enrollment announcement, but the surrounding research community has already treated gallbladder mucocele as an emerging disease with broader implications for comparative medicine. NC State has explicitly linked its CFTR findings to possible relevance for human cystic fibrosis-like disease, which may help sustain research attention and funding even as the immediate goal remains better risk stratification in dogs. (news.ncsu.edu)

What to watch: The next milestone will likely be whether NC State publishes a larger genomic analysis in enrolled Shetland Sheepdogs, and whether those findings translate into a clinically useful test or screening framework before enrollment closes on March 1, 2027. (cvm.ncsu.edu)